Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KONCLUDE: Consolidation vs Adjuvant FOLFOX in Rectal Cancer
NCT02843191Phase 3Active, not recruiting
- Sponsor
- Kyung Hee University Hospital
- Start
- Dec 2016
- Primary completion
- Jul 2023
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil, folinic acid in rectal cancer, sponsored by Kyung Hee University Hospital. Started Dec 2016; status: active, not recruiting.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02843191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02843191.